| Literature DB >> 33688537 |
Tanya Tandon1, Ashok Kumar Dubey1, Suparna Dubey2, Ekta Arora1, Md Nazer Hasan1.
Abstract
BACKGROUND: Many countries are implementing measures for social distancing to contain the spread of the coronavirus disease 2019 (COVID-19) pandemic. The Indian government also issued an order for complete lockdown of the country, with all the nonessential services, including most of the services for nonemergency health issues, being temporarily suspended.Entities:
Keywords: COVID-19; medical advice; self-medication
Year: 2021 PMID: 33688537 PMCID: PMC7933611 DOI: 10.4103/jehp.jehp_481_20
Source DB: PubMed Journal: J Educ Health Promot ISSN: 2277-9531
Medical problems in the study participants during lockdown (n=312)
| Details of participants | Number of participants |
|---|---|
| Participants with preexisting conditions (before lockdown) and new-onset symptoms (during lockdown) | 106 |
| Participants taking medication for previous conditions | 83 |
| Participants taking medication for new symptoms | 13 |
| Participants not taking medication for new-onset symptoms | 10 |
Health advice-seeking practices in the participants already on medications for preexisting conditions (n=83)
| Health advice-seeking practices | Number of participants |
|---|---|
| Continue to take medication as prescribed earlier | 66 |
| Consulted their doctor over phone | 11 |
| Visited their doctors personally after consulting them over phone | 2 |
| Stopped the medications on their own after completing the prescribed regimen | 4 |
Patients started on any new therapy during the lockdown
| Medication use | Number of participants |
|---|---|
| Due to new-onset problems | 13 |
| Advised by their doctor after consultation over phone | 9 |
| Advised by the doctor when they visited the emergency department | 4 |
| Prophylactic therapy with the perception to prevent COVID-19 infection | 4 |
| Hydroxychloroquine (self-medication) | 1 |
| Vitamin C tablets on their own | 2 |
COVID-19=Coronavirus disease 2019
Scheduled follow-up visits which could not take place due to lockdown (n=16)
| Reason for scheduled follow-up visits | Number of participants |
|---|---|
| Dose adjustment of new therapy after examination | 1 |
| Stoppage of medication after examination | 2 |
| Showing lab reports for therapeutic modifications, if any | 3 |
| To Review the treatment as not much relief | 2 |
| Routine follow-up without any specific objective | 6 |